Katalog der Deutschen Nationalbibliothek

Expertensuche ?

eingeschränkt auf
- Materialarten:	Artikel

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Der Multimedia-Zeitschriftenlesesaal und der Kartenlesesaal in Leipzig sind vom 30.10. bis 03.11. geschlossen. // The multimedia/periodical reading room and the map reading room in Leipzig are closed from 30.10 to 03.11.

Ergebnis der Suche nach: "106968971"
im Bestand: Gesamter Bestand

1 - 8 von 8

	1	Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study Alten, Rieke. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
	2	Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study Nüßlein, Hubert G.. - London : BioMed Central, 2016
	3	Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015
	4	High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2014
	5	Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2014
	6	Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study Enthalten in BMC public health Bd. 18, 20.2.2018, Nr. 1, date:12.2018: 1-13
	7	Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study Enthalten in BMC musculoskeletal disorders Bd. 16, 30.7.2015, Nr. 1, date:12.2015: 1-11
	8	Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study Enthalten in BMC musculoskeletal disorders Bd. 15, 11.1.2014, Nr. 1, date:12.2014: 1-13

1 - 8 von 8

Alle Materialarten > Artikel (8)

Alle Standorte

Aktionen

Administration